These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
712 related articles for article (PubMed ID: 16874413)
1. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids. Sato M Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413 [TBL] [Abstract][Full Text] [Related]
2. Wnt/β-catenin pathway forms a negative feedback loop during TGF-β1 induced human normal skin fibroblast-to-myofibroblast transition. Liu J; Wang Y; Pan Q; Su Y; Zhang Z; Han J; Zhu X; Tang C; Hu D J Dermatol Sci; 2012 Jan; 65(1):38-49. PubMed ID: 22041457 [TBL] [Abstract][Full Text] [Related]
3. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts. Wang Z; Gao Z; Shi Y; Sun Y; Lin Z; Jiang H; Hou T; Wang Q; Yuan X; Zhu X; Wu H; Jin Y J Plast Reconstr Aesthet Surg; 2007; 60(11):1193-9. PubMed ID: 17889631 [TBL] [Abstract][Full Text] [Related]
5. Cross-talk between TGF-β/Smad pathway and Wnt/β-catenin pathway in pathological scar formation. Sun Q; Guo S; Wang CC; Sun X; Wang D; Xu N; Jin SF; Li KZ Int J Clin Exp Pathol; 2015; 8(6):7631-9. PubMed ID: 26261683 [TBL] [Abstract][Full Text] [Related]
6. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Lee TY; Chin GS; Kim WJ; Chau D; Gittes GK; Longaker MT Ann Plast Surg; 1999 Aug; 43(2):179-84. PubMed ID: 10454326 [TBL] [Abstract][Full Text] [Related]
7. Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions. Phan TT; Lim IJ; Aalami O; Lorget F; Khoo A; Tan EK; Mukhopadhyay A; Longaker MT J Pathol; 2005 Oct; 207(2):232-42. PubMed ID: 16052471 [TBL] [Abstract][Full Text] [Related]
8. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics. Polo M; Smith PD; Kim YJ; Wang X; Ko F; Robson MC Ann Plast Surg; 1999 Aug; 43(2):185-90. PubMed ID: 10454327 [TBL] [Abstract][Full Text] [Related]
9. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars. Zhang ZF; Zhang YG; Hu DH; Shi JH; Liu JQ; Zhao ZT; Wang HT; Bai XZ; Cai WX; Zhu HY; Tang CW Burns; 2011 Jun; 37(4):665-72. PubMed ID: 21236582 [TBL] [Abstract][Full Text] [Related]
10. Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions. Tsujita-Kyutoku M; Uehara N; Matsuoka Y; Kyutoku S; Ogawa Y; Tsubura A In Vivo; 2005; 19(6):959-63. PubMed ID: 16277007 [TBL] [Abstract][Full Text] [Related]
11. Expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts in response to transforming growth factor beta1. Xie JL; Qi SH; Pan S; Xu YB; Li TZ; Liu XS; Liu P Dermatol Surg; 2008 Sep; 34(9):1216-24; discussion 1224-5. PubMed ID: 18616749 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of TGF-β1 in keloids and hypertrophic scars. Abdou AG; Maraee AH; Al-Bara AM; Diab WM Am J Dermatopathol; 2011 Feb; 33(1):84-91. PubMed ID: 20559120 [TBL] [Abstract][Full Text] [Related]
13. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Slemp AE; Kirschner RE Curr Opin Pediatr; 2006 Aug; 18(4):396-402. PubMed ID: 16914994 [TBL] [Abstract][Full Text] [Related]
14. Role of Smad3, acting independently of transforming growth factor-beta, in the early induction of Wnt-beta-catenin signaling by parathyroid hormone in mouse osteoblastic cells. Inoue Y; Canaff L; Hendy GN; Hisa I; Sugimoto T; Chihara K; Kaji H J Cell Biochem; 2009 Sep; 108(1):285-94. PubMed ID: 19582775 [TBL] [Abstract][Full Text] [Related]
15. Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts. Tang B; Zhu B; Liang Y; Bi L; Hu Z; Chen B; Zhang K; Zhu J Arch Dermatol Res; 2011 Oct; 303(8):563-72. PubMed ID: 21240513 [TBL] [Abstract][Full Text] [Related]
16. mTOR as a potential therapeutic target for treatment of keloids and excessive scars. Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482 [TBL] [Abstract][Full Text] [Related]
17. A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fibroblasts. Chu Y; Guo F; Li Y; Li X; Zhou T; Guo Y Connect Tissue Res; 2008; 49(2):92-8. PubMed ID: 18382895 [TBL] [Abstract][Full Text] [Related]
18. The molecular basis of keloid and hypertrophic scar formation. Tuan TL; Nichter LS Mol Med Today; 1998 Jan; 4(1):19-24. PubMed ID: 9494966 [TBL] [Abstract][Full Text] [Related]
19. Beta-catenin/LEF-1 signalling in breast cancer--central players activated by a plethora of inputs. Gebeshuber CA; Sladecek S; Grunert S Cells Tissues Organs; 2007; 185(1-3):51-60. PubMed ID: 17587808 [TBL] [Abstract][Full Text] [Related]
20. [Experimental study of actin and myosin in the scar tissue]. Zhang Q; Qian YL; Cui L Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):32-5. PubMed ID: 12563927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]